Pre-Transplant Consolidation Chemotherapy Does Not Improve Rates Of Relapse Following Reduced Intensity Conditioning (RIC) Hematopoietic Stem Cell Transplantation (HCT) For AML In CR1

S.E Mccormack,Q Cao,E.D Warlick

doi:10.1016/j.bbmt.2009.12.084

Pre-Transplant Consolidation Chemotherapy Does Not Improve Rates Of Relapse Following Reduced Intensity Conditioning (RIC) Hematopoietic Stem Cell Transplantation (HCT) For AML In CR1

S.E Mccormack, Q Cao + Show 1 more

Open Access

https://doi.org/10.1016/j.bbmt.2009.12.084

Copy DOI

Journal: Biology of Blood and Marrow Transplantation	Publication Date: Feb 1, 2010
License type: cc-by-nc-nd

Affiliation: University of Minnesota

#Reduced Intensity Conditioning Hematopoietic Stem Cell Transplantation #Hematopoietic Stem Cell Transplantation + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

RIC HCT is an evolving post-remission treatment modality for AML. While previous reports demonstrate no benefit to consolidation chemotherapy prior to myeloablative HCT, the impact on outcomes post RIC HCT is unknown.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Biology of Blood and Marrow Transplantation

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.